BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32416453)

  • 1. Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway.
    Mehta M; Gohil D; Khattry N; Kumar R; Sandur S; Sharma D; Checker R; Agarwal B; Jha D; Majumdar A; Gota V
    Int Immunopharmacol; 2020 Jul; 84():106575. PubMed ID: 32416453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect.
    Kumar Gupta S; Gohil D; Dutta D; Panigrahi GC; Gupta P; Dalvi K; Khanka T; Yadav S; Kumar Kaushal R; Chichra A; Punatar S; Gokarn A; Mirgh S; Jindal N; Nayak L; Tembhare PR; Khizer Hasan S; Kumar Sandur S; Hingorani L; Khattry N; Gota V
    Int Immunopharmacol; 2023 Aug; 121():110437. PubMed ID: 37311352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis of graft-versus-host disease in mice by chemical modification of graft and OX40-OX40L costimulatory pathway.].
    Huang YH; Feng SR; DU B; Xu KL; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):735-40. PubMed ID: 20137307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
    Hu WB; Gao QP; Chen YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
    Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
    Waller EK; Ship AM; Mittelstaedt S; Murray TW; Carter R; Kakhniashvili I; Lonial S; Holden JT; Boyer MW
    Blood; 1999 Nov; 94(9):3222-33. PubMed ID: 10556211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH
    Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of Infiltrating CD3
    Zhao K; Ruan SH; Tian Y; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):931-936. PubMed ID: 34105496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and Evaluation Strategy of an
    Tian JY; Li PL; Tang J; Xu RX; Yin BF; Wang FY; Li XT; Ning HM; Zhu H; Ding L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):617-624. PubMed ID: 38660875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.
    Johnson BD; Taylor PA; Stankowski MC; Talib S; Hearst JE; Blazar BR
    Biol Blood Marrow Transplant; 2002; 8(11):581-7. PubMed ID: 12463476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.
    Waller EK; Boyer M
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S20-4. PubMed ID: 10933181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
    Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
    J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
    Huang H; Zheng W; Lin M; Fu J; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.